Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-11.49%
operating margin TTM
-4.91%
revenue TTM
1.90 Billion
revenue per share TTM
14.55$
valuation ratios | |
|---|---|
| pe ratio | -188.07 |
| peg ratio | -51.01 |
| price to book ratio | 439.41 |
| price to sales ratio | 21.72 |
| enterprise value multiple | -332.23 |
| price fair value | 439.41 |
profitability ratios | |
|---|---|
| gross profit margin | 86.01% |
| operating profit margin | -4.91% |
| pretax profit margin | -15.13% |
| net profit margin | -11.49% |
| return on assets | -6.4% |
| return on equity | -509.33% |
| return on capital employed | -3.68% |
liquidity ratio | |
|---|---|
| current ratio | 3.04 |
| quick ratio | 2.98 |
| cash ratio | 0.95 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 72.88 |
| operating cycle | 137.86 |
| days of payables outstanding | 108.24 |
| cash conversion cycle | 29.62 |
| receivables turnover | 5.62 |
| payables turnover | 3.37 |
| inventory turnover | 5.01 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.31 |
| debt equity ratio | 11.28 |
| long term debt to capitalization | 0.90 |
| total debt to capitalization | 0.92 |
| interest coverage | -0.79 |
| cash flow to debt ratio | -0.03 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.58 |
| cash per share | 20.24 |
| operating cash flow per share | -0.35 |
| free cash flow operating cash flow ratio | 1.67 |
| cash flow coverage ratios | -0.03 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -1.49 |
Frequently Asked Questions
When was the last time Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported earnings?
Alnylam Pharmaceuticals, Inc. (ALNY) published its most recent earnings results on 01-05-2025.
What is Alnylam Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)'s trailing twelve months ROE is -509.33%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Alnylam Pharmaceuticals, Inc. (ALNY) currently has a ROA of -6.4%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ALNY's net profit margin stand at?
ALNY reported a profit margin of -11.49% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ALNY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.04 in the most recent quarter. The quick ratio stood at 2.98, with a Debt/Eq ratio of 11.28.